PARV4: An Emerging Tetraparvovirus
article has not abstract
Vyšlo v časopise:
PARV4: An Emerging Tetraparvovirus. PLoS Pathog 10(5): e32767. doi:10.1371/journal.ppat.1004036
Kategorie:
Pearls
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1004036
Souhrn
article has not abstract
Zdroje
1. JonesMS, KapoorA, LukashovVV, SimmondsP, HechtF, et al. (2005) New DNA viruses identified in patients with acute viral infection syndrome. J Virol 79: 8230–8236.
2. LouS, XuB, HuangQ, ZhiN, ChengF, et al. (2012) Molecular characterization of the newly identified human parvovirus 4 in the family Parvoviridae. Virology 422: 59–69.
3. YuX, ZhangJ, HongL, WangJ, YuanZ, et al. (2012) High prevalence of human parvovirus 4 infection in HBV and HCV infected individuals in shanghai. PLoS One 7: e29474.
4. ManningA, WilleySJ, BellJE, SimmondsP (2007) Comparison of tissue distribution, persistence, and molecular epidemiology of parvovirus B19 and novel human parvoviruses PARV4 and human bocavirus. J Infect Dis 195: 1345–1352.
5. SimmondsP, DouglasJ, BestettiG, LonghiE, AntinoriS, et al. (2008) A third genotype of the human parvovirus PARV4 in sub-Saharan Africa. J Gen Virol 89: 2299–2302.
6. PanningM, KobbeR, VollbachS, DrexlerJF, AdjeiS, et al. (2010) Novel human parvovirus 4 genotype 3 in infants, Ghana. Emerg Infect Dis 16: 1143–1146.
7. SharpCP, LeBretonM, KantolaK, NanaA, Diffo JleD, et al. (2010) Widespread infection with homologues of human parvoviruses B19, PARV4, and human bocavirus of chimpanzees and gorillas in the wild. J Virol 84: 10289–10296.
8. AdlhochC, KaiserM, LoewaA, UlrichM, ForbrigC, et al. (2012) Diversity of parvovirus 4-like viruses in humans, chimpanzees, and monkeys in hunter-prey relationships. Emerg Infect Dis 18: 859–862.
9. SimmonsR, SharpC, McClureCP, RohrbachJ, KovariH, et al. (2012) Parvovirus 4 infection and clinical outcome in high-risk populations. J Infect Dis 205: 1816–1820.
10. SimmonsR, SharpC, LevineJ, BownessP, SimmondsP, et al. (2013) Evolution of CD8+ T cell responses after acute PARV4 infection. J Virol 87: 3087–3096.
11. SharpCP, LailA, DonfieldS, GompertsED, SimmondsP (2012) Virologic and clinical features of primary infection with human parvovirus 4 in subjects with hemophilia: frequent transmission by virally inactivated clotting factor concentrates. Transfusion 52: 1482–1489.
12. LavoieM, SharpCP, PepinJ, PenningtonC, FoupouapouognigniY, et al. (2012) Human parvovirus 4 infection, Cameroon. Emerg Infect Dis 18: 680–683.
13. ChenMY, YangSJ, HungCC (2011) Placental transmission of human parvovirus 4 in newborns with hydrops, Taiwan. Emerg Infect Dis 17: 1954–1956.
14. FryerJF, DelwartE, HechtFM, BernardinF, JonesMS, et al. (2007) Frequent detection of the parvoviruses, PARV4 and PARV5, in plasma from blood donors and symptomatic individuals. Transfusion 47: 1054–1061.
15. SharpCP, VermeulenM, NebieY, DjokoCF, LeBretonM, et al. (2010) Epidemiology of human parvovirus 4 infection in sub-Saharan Africa. Emerg Infect Dis 16: 1605–1607.
16. DrexlerJF, ReberU, MuthD, HerzogP, AnnanA, et al. (2012) Human parvovirus 4 in nasal and fecal specimens from children, ghana. Emerg Infect Dis 18: 1650–1653.
17. LauSK, WooPC, TseH, FuCT, AuWK, et al. (2008) Identification of novel porcine and bovine parvoviruses closely related to human parvovirus 4. J Gen Virol 89: 1840–1848.
18. MayJ, DrexlerJF, ReberU, SarpongN, AdjeiO, et al. (2012) Human parvovirus 4 viremia in young children, ghana. Emerg Infect Dis 18: 1690–1692.
19. SharpCP, LailA, DonfieldS, SimmonsR, LeenC, et al. (2009) High frequencies of exposure to the novel human parvovirus PARV4 in hemophiliacs and injection drug users, as detected by a serological assay for PARV4 antibodies. J Infect Dis 200: 1119–1125.
20. SimmonsR, SharpC, SimsS, KloverprisH, GoulderP, et al. (2011) High frequency, sustained T cell responses to PARV4 suggest viral persistence in vivo. J Infect Dis 203: 1378–1387.
21. BenjaminLA, LewthwaiteP, VasanthapuramR, ZhaoG, SharpC, et al. (2011) Human parvovirus 4 as potential cause of encephalitis in children, India. Emerg Infect Dis 17: 1484–1487.
22. ValleriniD, BarozziP, QuadrelliC, BoscoR, PotenzaL, et al. (2008) Parvoviruses in blood donors and transplant patients, Italy. Emerg Infect Dis 14: 185–186.
23. CotmoreSF, Agbandje-McKennaM, ChioriniJA, MukhaDV, PintelDJ, et al. (2013) The family Parvoviridae. Arch Virol E-pub ahead of print.
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2014 Číslo 5
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Venus Kinase Receptors Control Reproduction in the Platyhelminth Parasite
- Dual-Site Phosphorylation of the Control of Virulence Regulator Impacts Group A Streptococcal Global Gene Expression and Pathogenesis
- Severe Acute Respiratory Syndrome Coronavirus Envelope Protein Ion Channel Activity Promotes Virus Fitness and Pathogenesis
- High-Efficiency Targeted Editing of Large Viral Genomes by RNA-Guided Nucleases